AAP
ABVX icon

Arax Advisory Partners’s Abivax ABVX Stock Holding History

Arax Advisory Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.93K Buy
+37
New +$4.19K ﹤0.01% 4599
2026
Q1 		– Sell
-62
Closed -$8.36K – 3769
2025
Q4 		$8.36K Buy
+62
New +$6.76K ﹤0.01% 2566

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arax Advisory Partners's ABVX Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Abivax (ABVX) in Q2 2026: 37 shares worth $4.93K. The stake represents ﹤0.01% of the portfolio and ranks #4599 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in ABVX as recently as Q4 2025.

Arax Advisory Partners first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $8.36K in Q4 2025. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Arax Advisory Partners held 37 shares of Abivax worth $4.93K as of Q2 2026.
  • Abivax was a new Arax Advisory Partners position in Q2 2026.
  • Abivax made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4599 holding.
  • Arax Advisory Partners first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Arax Advisory Partners's Abivax position peaked at $8.36K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.